Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma

Diseases of the Colon and Rectum

Volumn 52, Issue 6, 2009, Pages 1166-1171

  Belizon, Avraham ^a   Balik, Emre ^a   Horst, Patrick K ^a   Kumara, H M C Shantha ^a   Nasar, Abu ^a   Whelan, Richard L ^a,b  

^a Presbyterian Hospital ^*  (United States)

^b Milstein Hospital   (United States)

Author keywords

Colorectal cancer; Plasma tumor marker; Platelet derived growth factor

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB; TUMOR MARKER;

ADENOMA; AGED; ARTICLE; BENIGN TUMOR; BLOOD ANALYSIS; CANCER STAGING; CANCER SURGERY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; BLOOD; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; NONPARAMETRIC TEST; STATISTICAL MODEL;

ADENOMA; AGED; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PLATELET-DERIVED GROWTH FACTOR; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 68049141870     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181a0b388     Document Type: Article

References (39)

1. Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K, Tanikawa K. Circulating vascular growth factor in patients with colorectal cancer. Am J Gastroenterol 1998;93:249-252 (Pubitemid 29063978)
2. Fidler IJ. The pathogenesis of cancer metastasis: 'The Seed and the Soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-458
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
5. Cao R, Brakenheilm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003;9:604-613 (Pubitemid 36597108)
6. Lindahl P, Johansson BR, Leveen P, Batsholtz C. Pericyte loss and microaneurysm formation in PDGF-B deficient mice. Science 1997;277:242-245 (Pubitemid 27446080)
7. Coltrera MD, Wang J, Porter PL, Gown AM. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Cancer Res 1995;55:2703-2708
8. Safi A, Sadmi M, Martinet N, et al. Presence of elevated levels of platelet-derived growth factor (PDGF) in lung adenocarcinoma pleural effusions. Chest 1992;102:204-207
9. Soderdahl G, Betsholtz C, Johansson A, Nilsson K, Bergh J. Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines. Int J Cancer 1988;41:636-641 (Pubitemid 18108709)
10. Nakamura Y, Tanaka F, Yoshikawa Y, et al. PDGF-BB is a novel prognostic factor in colorectal cancer. Ann Surg Oncol 2008;15:2129-2136
11. Kawai T, Hiroi S, Troikata C. Expression in lung carcinomas of platelet derived growth factor and its receptors. Lab Invest 1997;77:431-436 (Pubitemid 27508614)
12. Kazlauskas A. A new member of an old family. Nat Cell Biol 2000;2:E78-9.
13. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
14. Folkman J. Addressing tumor blood vessels. Nat Biotechnol 1997;15:510.
15. Cao R, Wu HL, Veitonmaki N, et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc Natl Acad Sci USA 1999;96:5728-5733 (Pubitemid 29234686)
16. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22. (Pubitemid 29038270)
17. Hyodo I, Doi T, Endo H, et al. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer 1998;34:2041-2045 (Pubitemid 28546939)
18. Takeda A, Shimada H, Imaseki H, et al. Clinical significance of serum endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers. Oncol Rep 2000;7:333-338
19. Kumar H, Heer K, Lee PW, et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 1998;4:1279-1285 (Pubitemid 28213341)
20. Kitamura M, Toi M, Arai K, Iwasaki Y, Suzuki H, Matsuo K. Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients. Oncol Rep 1998;5:1419-1424 (Pubitemid 28474087)
21. Thommen R, Humar R, Misevic G, et al. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J Cell Biochem 1997;64:403-413 (Pubitemid 27098626)
22. Wang D, Huang HJ, Kazlauskas A, Cavenee WK. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res 1999;59:1464-1472 (Pubitemid 29160112)
23. Cao R, Brakenhielm E, Li X, et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J 2002;16:1575-1583 (Pubitemid 35154640)
24. Cao R, Bjorndahl MA, Religa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004;6:333-345 (Pubitemid 39361435)
25. Cao Y. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cell Cycle 2005;4:228-230 (Pubitemid 41365322)
26. Filiberti R, Marroni P, Neri M, et al. Serum PDGF-AB in pleural mesothelioma. Tumor Biol 2005;26:221-226
27. Lee SW, Gleason NR, Stapleton GS, et al. Increased platelet-derived growth factor (PDGF) release after laparotomy stimulates systemic tumor growth in mice. Surg Endosc 2001;15:981-985
28. Chiang K-C, Chen T-W, Yeh C-N, Liu F-Y, Lee H-L, Jan Y-Y. Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate. World J Gastroenterol 2006;7:2060-2064
29. Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A. PDGF receptors as cancer drug targets. Cancer Cell 2003;3:439-443 (Pubitemid 38340290)
30. Kuwahara A, Katano M, Nakamura M, et al. New therapeutic strategy for gastric carcinoma: a two step evaluation of malignant potential from its molecular biologic and pathologic characteristics. J Surg Oncol 1999;72:142-149
31. Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res 2005;7:R788-95.
32. Anan K, Morisaki T, Katano M, et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996;119:333-339 (Pubitemid 26082669)
33. Seymour L, Bezwoda WR. Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer. Breast Cancer Res Treat 1994;32:229-233 (Pubitemid 24313348)
34. Shikada Y, Yonemitsu Y, Koga T, et al. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res 2005;65:7241-7248 (Pubitemid 41161255)
35. Sulzbacher I, Birner P, Trieb K, Traxler M, Lang S, Chott A. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma. Mod Pathol 2003;16:66-71. (Pubitemid 36152688)
36. Katano M, Nakamura M, Fujimoto K, Miyazaki K, Morisaki T. Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Ann Surg 1998;227:365-371 (Pubitemid 28131017)
37. Ko YJ, Small EJ, Kabbinavar F, et al. A multi-institutional phase II study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer. Clin Cancer Res 2001;7:800-805 (Pubitemid 32708713)
38. Barnhill RL, Xiao M, Graves D, Antoniades HN. Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo. Br J Dermatol 1996;135:898-904. (Pubitemid 26397917)
39. Takanami I, Imamura T, Yamamoto Y, Kodaira S. Usefulness of platelet-derived growth factor as a prognostic factor in pulmonary adenocarcinoma. J Surg Oncol 1995;58:40-43